Dusseldorf Pharma Private Limited
About Dusseldorf Pharma Private Limited
Data last updated:
Dusseldorf Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC367955. Its GSTIN is 27AAICD7656E1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹3 Lakh. It is led by directors Chintan U Joshi and Kamalakar Ramakant Samant.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 – A Shree Laxmi Park – I Building C – 3 Lokmanya Nagar, Thane, Maharashtra, India – 400606.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.6 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.17 Lakh (net margin 0.3%) and EBITDA of ₹3.07 Lakh (EBITDA margin 0.5%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dusseldorf Pharma Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address201 – A Shree Laxmi Park – I Building C – 3 Lokmanya Nagar, Thane, Maharashtra, India – 400606
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dusseldorf Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dusseldorf Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Dusseldorf Pharma Private Limited, buy the company report.
Financials of Dusseldorf Pharma Private Limited
FY 2025 filings availableDusseldorf Pharma Private Limited reported revenue of ₹6.6 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year. EBITDA fell 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.07 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.17 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.5% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dusseldorf Pharma Private Limited, buy the company report.
Board of directors of Dusseldorf Pharma Private Limited
Dusseldorf Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chintan U Joshi | Director | 22 Sep 2021 | 5 Years 1 Months | Current |
| Kamalakar Ramakant Samant Also directs: Scooolio Technologies Private Limited | Director | 22 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Dusseldorf Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M P International Private Limited | ₹6.61 Cr (FY 2020) | -74.0% | Mumbai, Maharashtra, India | |||
| T S Informatics Private Limited | ₹6.61 Cr (FY 2025) | 105.0% | New Delhi, Delhi, India | |||
| Altux Innovation Private Limited | ₹6.6 Cr (FY 2025) | 20.0% | Jaipur, Rajasthan, India | |||
| Trishul Cement Pvt Ltd | ₹6.6 Cr (FY 2025) | 188.0% | Rourkela, Odisha, India | |||
| Bhiksu Barter Pvt Ltd | ₹6.6 Cr (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Dusseldorf Pharma Private Limited this company | ₹6.6 Cr (FY 2025) | ₹2.17 Lakh | 0.3% | -2.0% | Thane, Maharashtra, India | |
| Anand Kitchens and Hardware Private Limited | ₹6.6 Cr (FY 2025) | -3.0% | Karnal, Haryana, India | |||
| Hontrade International Private Limited | ₹6.6 Cr (FY 2025) | 44.0% | Delhi, India | |||
| Sa Computer World Solutions Private Limited | ₹6.6 Cr (FY 2016) | -15.0% | Mumbai, Maharashtra, India | |||
| Biome Healthcare Private Limited | ₹6.6 Cr (FY 2025) | 15.0% | Bangalore, Karnataka, India | |||
| Wonda Superstores India Private Limited | ₹6.6 Cr (FY 2024) | 14.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Dusseldorf Pharma Private Limited, buy the company report.
Auditor
Dusseldorf Pharma Private Limited is audited by VISHAL JOSHI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VISHAL JOSHI & CO | FY 2023 | 131606W |
Shareholding
The shareholding of Dusseldorf Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dusseldorf Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dusseldorf Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dusseldorf Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dusseldorf Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Dusseldorf Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICD7656E1ZF | Maharashtra | Active | 27 Sep 2021 |
To see the full GST registrations and return filing status of Dusseldorf Pharma Private Limited, buy the company report.
Recent activity
Dusseldorf Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Chintan U Joshi was appointed as Director on 22 Sep 2021.
Frequently asked questions
Dusseldorf Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 September 2021 (5+ years old) and is registered under CIN U24290MH2021PTC367955.
Dusseldorf Pharma has 2 current directors:
- Chintan U Joshi - Director
- Kamalakar Ramakant Samant - Director
The latest financial statements of Dusseldorf Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Dusseldorf Pharma is 27AAICD7656E1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dusseldorf Pharma is U24290MH2021PTC367955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dusseldorf Pharma was incorporated on 22 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dusseldorf Pharma by revenue are M P International Private Limited, T S Informatics Private Limited, Altux Innovation Private Limited, Trishul Cement Pvt Ltd, Bhiksu Barter Pvt Ltd and 5 more, all in the same principal business activity (retail trading).
Chintan U Joshi was appointed as Director on 22 Sep 2021. Kamalakar Ramakant Samant was appointed as Director on 22 Sep 2021.
The registered office of Dusseldorf Pharma is at 201 – A Shree Laxmi Park – I Building C – 3 Lokmanya Nagar, Thane, Maharashtra, India – 400606.
Dusseldorf Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Dusseldorf Pharma is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.